Cetris Oncology Solutions
Certis Oncology Solutions was formed in 2016 with the mission to provide individualized precision patient care. their patient-directed therapy enables oncologists to tailor and optimize therapies for patients suffering from aggressive cancers. they also provide pre-clinical services for pharmaceutical and biotech companies.
$10M
Latest Funding
Series C
Latest Funding Stage
2024-01-17
Funding Date
43
Employees
United States
Location
New York, New York
City & State
Sales-Ready Summary
Certis Oncology Solutions recently raised a $10M Series C and utilizes HubSpot for marketing automation and Salesforce for CRM, suggesting they are scaling their sales and marketing efforts and could benefit from sales enablement or marketing optimization tools.
Key Contacts
Open Positions
View Careers PageHiring For
Similar Startups
Eikon Therapeutics
Eikon Therapeutics is a biopharmaceutical company that focuses on developing innovative technologies for drug discovery. The company utilizes advanced live-cell resolution microscopy and engineering to identify and create new therapeutic candidates. Eikon Therapeutics aims to enhance the understanding of biological processes at a cellular level,supporting targeted treatment development.
Arsenale Bioyards
Arsenale is transforming biomanufacturing with a proprietary end-to-end platform that integrates advanced hardware, AI-driven software, and precision fermentation. Designed to bridge the gap from lab-scale innovation to industrial-scale production, Arsenale enables industries like food, chemicals, and materials to seamlessly develop and scalebio-based alternatives to petrochemicals and animal-derived products.
EvidenceHunt
EvidenceHunt is an AI-powered research assistant developed by medical professionals for healthcare research. Our focus is on delivering tools that streamline gathering and analyzing clinical evidence. With features like AI Chat for interactive queries and comprehensive Direct Search options, EvidenceHunt allows precise data retrieval andanalysis.
Avitia
Avitia improves cancer treatment via advanced molecular testing solutions. Avitia offer testing tools for use on-site, bioinformatics driven by AI, and actionable insights aimed at enhancing patient outcomes. Avitia offerings comprise pre-prepared NGS panels, simplified reporting mechanisms, and cooperative diagnostic platforms.